Anemia and markers of erythropoiesis in pediatric kidney transplant recipients compared to children with chronic renal failure
Corresponding Author
Irit Krause
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Correspondence
Irit Krause, Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel.
Email: [email protected]
Search for more papers by this authorMiriam Davidovits
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Search for more papers by this authorHannah Tamary
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Pediatric Hematology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Search for more papers by this authorMaria Yutcis
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Search for more papers by this authorAmit Dagan
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Search for more papers by this authorCorresponding Author
Irit Krause
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Correspondence
Irit Krause, Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel.
Email: [email protected]
Search for more papers by this authorMiriam Davidovits
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Search for more papers by this authorHannah Tamary
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Pediatric Hematology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Search for more papers by this authorMaria Yutcis
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Search for more papers by this authorAmit Dagan
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel
Search for more papers by this authorAbstract
PTA and anemia of CKD share a similar pathogenesis. However, PTA may be disproportionate to the reduction in the GFR. Data relating to the mechanism of PTA are scarce. We evaluated the erythropoiesis parameters in pediatric kidney recipients compared to children with CKD. A total of 100 patients (54 post-kidney TX, 46 with CKD) were enrolled in the single-center cohort study. GFR was found to be significantly lower in the CKD group (49.7±22.4 vs 72.9±28.5 mL/min/1.73 m², P<.001); anemia was significantly more common in the TX patients (52% vs 41.3%, P<.001). Iron transferrin saturation and serum ferritin levels were lower in the CKD patients. In both groups, hemoglobin Z scores significantly correlated with GFR (R=.31, P=.07). This correlation was more prominent in the CKD group (R=.43, P=.008) compared to the TX group (R=.31, P=.04). Anemia was significantly more common in the TX patients than in the CKD patients despite a better GFR. The higher prevalence of anemia in the TX group could not be explained by an iron deficiency or reduced EPO production. We speculate that immunosuppressive therapy together with resistance to EPO may play a role in the pathogenesis of post-transplantation anemia.
References
- 1Tonshoff B, Hocker B. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant. 2006; 10: 721–729.
- 2Sinha R, Saad A, Marks SD. Prevalence and complications of chronic kidney disease in paediatric renal transplantation: a K/DOQI perspective. Nephrol Dial Transplant. 2010; 25: 1313–1320.
- 3Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis. 2002; 40: 1306–1318.
- 4Kausman JY, Powell HR, Jones CL. Anemia in pediatric renal transplant recipients. Pediatr Nephrol. 2004; 19: 526–530.
- 5Mitsnefes MM, Subat-Dezulovic M, Khoury PR, Goebel J, Strife CF. Increasing incidence of post-kidney transplant anemia in children. Am J Transplant. 2005; 5: 1713–1718.
- 6Chadban SJ, Baines L, Polkinghorne K, et al. Anemia after kidney transplantation is not completely explained by reduced kidney function. Am J Kidney Dis. 2007; 49: 301–309.
- 7Ghafari A, Noori-Majelan N. Anemia among long-term renal transplant recipients. Transplant Proc. 2008; 40: 186–188.
- 8Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996; 7: 158–165.
- 9Yabu JM, Winkelmayer WC. Posttransplantation anemia: mechanisms and management. Clin J Am Soc Nephrol. 2001; 6: 1794–1801.
10.2215/CJN.01190211 Google Scholar
- 10Galutira PJ, del Rio M. Understanding renal posttransplantation anemia in the pediatric population. Pediatr Nephrol. 2012; 27: 1079–1085.
- 11Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20: 629–637.
- 12Eleftheruadus T, Liakopoulos V, Antoniadi G, Stefanidis I. Which is the best way for estimating transferrin saturation? Ren Fail. 2010; 32: 1022–1023.
- 13Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest. 1997; 100: 2310–2314.
- 14Malyszko J, Oberbauer R, Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int. 2012; 25: 1013–1023.
- 15Reindl-Schwaighofer R, Oberbauer R. Blood disorders after kidney transplantation. Transplant Rev (Orlando). 2014; 28: 63–75.
- 16Kawada N, Moriyama T, Ichimaru N, et al. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol. 2009; 13: 355–360.
- 17Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 2003; 14: 462–468.
- 18Gheith O, Wafa E, Hassan N, et al. Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience Clin Exp Nephrol. 2009; 13: 361–366.
- 19Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol. 2006; 81: 832–837.
- 20Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. 1979; 54: 877–884.
- 21Molnar MZ, Tabak AG, Alam A, et al. Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol. 2011; 6: 2879–2886.
- 22Molnar MZ, Czira ME, Rudas A, et al. Association between the malnutrition-inflammation score and post-transplant anaemia. Nephrol Dial Transplant. 2011; 26: 2000–2006.
- 23Wang AY, Yu AW, Lam CW, et al. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Dis. 2002; 39: 600–608.
- 24Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004; 15: 1347–1352.
- 25Turkowski-Duhem A, Kamar N, Cointault O, et al. Predictive factors of anemia within the first year post renal transplant. Transplantation. 2005; 80: 903–909.
- 26Wang K, Zhang H, Li Y, et al. Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systemic review. Transplant Proc. 2004; 36: 2071–2072.
- 27Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol. 2006; 17: 3240–3247.
- 28Pile T, Kieswich J, Harwood S, Yaqoob MM. A possible explanation for anemia in patients treated with mycophenolic acid. Transplantation. 2011; 92: 1316–1321.
- 29Jacobson PA, Schladt D, Oetting WS, et al. Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Transplantation. 2011; 91: 309–316.
- 30Al-Uzri A, Yorgin PD, Kling PJ. Anemia in children after transplantation etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant. 2003; 7: 253–264.
- 31Vanucchi AM, Grossi A, Bos A, et al. Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line. Blood. 1993; 82: 978–984.
- 32Peter C, Latta K, Graf D, Offner G, Brodehl J. Does tacrolimus cause more severe anemia than cyclosporine A in children after renal transplantation? Transpl Int. 1998; 11: S328–S330.
- 33Krischock LE, Vanstralen KJ, Verrina E, et al. Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry. Pediatr Nephrol. 2016; 31: 325–333.
- 34Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation. 2001; 72: 13–21.